1. Activation of Peroxisome Proliferator-Activated Receptor-γ Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator System
   Hirozumi Sawai et al, 2006, Molecular Cancer Research CrossRef
2. A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes
   Chunhua Qin et al, 2004, Molecular Cancer Therapeutics CrossRef
3. Peroxisome Proliferator-Activated Receptor γ Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times
   Glen Kristiansen et al, 2006, Clinical Cancer Research CrossRef
4. Chronic Pancreatitis and Pancreatic Cancer
   Xiangyu Kong et al, 2014, Gastrointestinal Tumors CrossRef
5. Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme
   Claire L. Varley et al, 2004, Journal of Cell Science CrossRef
6. Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth
   Laura A. Marlow et al, 2009, Cancer Research CrossRef
7. How cancer cells remodel lipid metabolism: strategies targeting transcription factors
   Do-Won Jeong et al, 2021, Lipids in Health and Disease CrossRef
8. Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer
   Ammu V. V. V. Ravi Kiran et al, 2022, Investigational New Drugs CrossRef